Association of the MCP-1 gene polymorphism A-2518G with carpal-tunnel syndrome in hemodialysis patients

References

• Gejyo F, Yamada T, Odani S, Nakagawa Y, Arakawa M, Kunitomo T, Kataoka H, Suzuki M, Hirasawa Y, Shirahama T, Cohen A S, Schmid K. A new form of amyloid protein associated with chronic hemodialysis was identified as beta 2-microglobulin. Biochem Biophys Res Commun 1985; 129: 701–706
   PubMed Web of Science ®Google Scholar
• Gejyo F, Odani S, Yamada T, Honma N, Saito H, Suzuki Y, Nakagawa Y, Kobayashi H, Maruyama Y, Hirasawa Y, Suzuki M, Arakawa M. Beta 2-microglobulin: a new form of amyloid protein associated with chronic hemodialysis. Kidney Int 1986; 30: 385–390
   PubMed Web of Science ®Google Scholar
• Sethi D, Gower P E. Synovial-fluid beta 2-microglobulin levels in dialysis arthropathy. N Engl J Med 1986; 315: 1419–1420
   PubMed Web of Science ®Google Scholar
• Homma N, Gejyo F, Isemura M, Arakawa M. Collagen-binding affinity of beta-2-microglobulin, a preprotein of hemodialysis-associated amyloidosis. Nephron 1989; 53: 37–40
   PubMed Web of Science ®Google Scholar
• Argiles A, Mourad G, Kerr P G, Garcia M, Collins B, Demaille J G. Cells surrounding haemodialysis-asso-ciated amyloid deposits are mainly macrophages. Nephrol Dial Transplant 1994; 9: 662–667
   PubMed Web of Science ®Google Scholar
• Gejyo F, Maruyama H, Teramura T, Kazama J, Ei I, Arakawa M. Role of macrophages in beta 2-microglobulin-related dialysis amyloidosis. Contrib Nephrol 1995; 112: 97–104
   PubMedGoogle Scholar
• Inoue H, Saito I, Nakazawa R, Mukaida N, Matsushima K, Azuma N, Suzuki M, Miyasaka N. Expression of inflammatory cytokines and adhesion molecules in haemodialysis-associated amyloidosis. Nephrol Dial Transplant 1995; 10: 2077–2082
   PubMed Web of Science ®Google Scholar
• Chronopoulos S, Laird D W, Ali-Khan Z. Immunolocalization of serum amyloid A and AA amyloid in lysosomes in murine monocytoid cells: confocal and immunogold electron microscopic studies. J Pathol 1994; 173: 361–369
   PubMed Web of Science ®Google Scholar
• Vincent C, Chanard J, Caudwell V., Lavaud S, Wong T, Revillard J P. Kinetics of 1251-beta 2-microglobulin turnover in dialyzed patients. Kidney Int 1992; 42: 1434–1443
   PubMed Web of Science ®Google Scholar
• Chanard J, Vincent C, Caudwell V, Lavaud S, Toupance O, Wong T, Revillard J P. Beta 2-microglobulin metabolism in uremic patients who are undergoing dialysis. Kidney Int Suppl 1993; 41: S83–87
   Google Scholar
• Kazama J J, Arakawa M, Gejyo F. Synovial inflammatory cells captured 1311-beta 2-microglobulin in patients with dialysis related amyloidosis. Amyloid Int J Exp Invest 1998; 5: 24–29
   PubMed Web of Science ®Google Scholar
• Garcia-Garcia Argiles M, Gouin-Charnet A, Durfort M, Garcia-Valero J, Mourad G. Impaired lysosomal processing of beta2-microglobulin by infiltrating macrophages in dialysis amyloidosis. Kidney Int 1999; 55: 899–906
   PubMed Web of Science ®Google Scholar
• Leonard E J, Yoshimura T. Human monocyte chemoattractant protein-1 (MCP-1). Immunol Today 1990; 11: 97–101
   PubMedGoogle Scholar
• Baggiolini M, Dewald B, Moser B. lnterleukin-8 and related chemotactic cytokines–CXC and CC chemokines. Adv Immunol 1994; 55: 97–179
   PubMed Web of Science ®Google Scholar
• Wolpe S D, Cerami A. Macrophage inflammatory proteins 1 and 2: members of a novel superfamily of cytokines. Faseb J 1989; 3: 2565–2573
   PubMed Web of Science ®Google Scholar
• Villiger P M, Terkeltaub R, Lotz M. Production of monocyte chemoattractant protein-1 by inflamed synovial tissue and cultured synoviocytes. J Immunol 1992; 149: 722–727
   PubMed Web of Science ®Google Scholar
• Koch A E, Kunkel S L, Harlow L A., Mazarakis D D, Haines G K, Burdick M D, Pope R M, Strieter R M. Macrophage inflammatory protein-1 alpha. A novel chemotactic cytokine for macrophages in rheumatoid arthritis. J Clin Invest 1994; 93: 921–928
   PubMed Web of Science ®Google Scholar
• Ueda A, Okuda K, Ohno S, Shirai A., Igarashi T, Matsunaga K, Fukushima J, Kawamoto S, Ishigatsubo Y, Okubo T. NF-kappa B and Spl regulate transcription of the human monocyte chemoattractant protein-1 gene. J Immunol 1994; 153: 2052–2063
   PubMed Web of Science ®Google Scholar
• Rovin B H, Lu L, Saxena R. A novel polymorphism in the MCP-1 gene regulatory region that influences MCP-1 expression. Biochem Biophys Res Commun 1999; 259: 344–348
   PubMed Web of Science ®Google Scholar
• Al-Sharif F M, Makki R F, Oilier W E, Hajeer A H. A new microsatellite marker within the promoter region of the MIP-1A gene. Immunogenetics 1999; 49: 740–741
   PubMed Web of Science ®Google Scholar
• Daugirdas J T. Second generation logarithmic estimates of single-pool variable volume Kt/V: an analysis of error. J Am Soc Nephrol 1993; 4: 1205–1213
   PubMed Web of Science ®Google Scholar
• Van Ypersele de Strihou C, Jadoul M, Malghem J, Maldague B, Jamart J. Effect of dialysis membrane and patient's age on signs of dialysis- related amyloidosis. The Working Party on Dialysis Amyloidosis. Kidney Int 1991; 39: 1012–1019
   PubMed Web of Science ®Google Scholar
• Davison A M. Beta 2-microglobulin and amyloidosis: who is at risk. Nephrol Dial Transplant 1995; 10: 48–51
   PubMed Web of Science ®Google Scholar
• Gejyo F, Kimura H, Suzuki S, Miyazaki R, Naiki H, Nakakuki K. Apolipoprotein E and alpha 1-antichymotrypsin in dialysis-related amyloidosis. Kidney Int Suppl 1997; 62: S75–78
   Google Scholar
• Miyata T, Oda O, Inagi R, Iida Y, Araki N, Yamada N, Horiuchi S, Taniguchi N, Maeda K, Kinoshita T. beta 2-Microglobulin modified with advanced glycation end products is a major component of hemodialysis-associated amyloidosis. J Clin Invest 1993; 92: 1243–1252
   PubMed Web of Science ®Google Scholar
• Miyata T, Inagi R, Iida Y, Sato M, Yamada N, Oda O, Maeda K, Seo H. Involvement of beta 2-microglobulin modified with advanced glycation end products in the pathogenesis of hemodialysis-associated amyloidosis. Induction of human monocyte chemotaxis and macrophage secretion of tumor necrosis factor-alpha and interleukin-1. J Clin Invest 1994; 93: 521–528
   PubMed Web of Science ®Google Scholar
• Witko-Sarsat V, Friedlander M, Capeillere-Blandin C, Nguyen-Khoa T, Nguyen A T, Zingraff J, Jungers P, Descamps-Latscha B. Advanced oxidation protein products as a novel marker of oxidative stress in uremia. Kidney Int 1996; 49: 1304–1313
   PubMed Web of Science ®Google Scholar
• Garbar C, Jadoul M, Noel H, Van Ypersele de Strihou C. Histological characteristics of sternoclavicular beta 2-microglobulin amyloidosis and clues for its histogenesis. Kidney Int 1999; 55: 1983–1990
   PubMed Web of Science ®Google Scholar
• Miyata T, Iida Y, Ueda Y, Shinzato Seo T. H, Monnier V M, Maeda K, Wada Y. Monocyte/macrophage response to beta 2-microglobulin modified with advanced glycation end products. Kidney Int 1996; 49: 538–550
   PubMed Web of Science ®Google Scholar
• Szalai C, Kozma G T, Nagy A, Bojszko A, Krikovszky D, Szabo T, Falus A. Polymorphism in the gene regulatory region of MCP-1 is associated with asthma susceptibility and severity. J Allergy Clin Immunol 2001; 108: 375–381
   PubMed Web of Science ®Google Scholar
• Szalai C, Duba J, Prohaszka Z, Kalina A, Szabo T, Nagy B, Horvath L, Csaszar A. Involvement of polymorphisms in the chemokine system in the susceptibility for coronary artery disease (CAD). Coincidence of elevated Lp(a) and MCP-1 -2518 G/G genotype in CAD patients. Atherosclerosis 2001; 158: 233–239
   PubMed Web of Science ®Google Scholar
• Martin E R, Lai E H, Gilbert J R, Rogala A R, Afshari A J, Riley J, Finch K L, Stevens J F, Livak K J, Slotterbeck B D, Slifer S H, Warren L L, Conneally P M, Schmechel D E, Purvis I, Pericak-Vance M A, Roses A D, Vance J M. SNPing away at complex diseases: analysis of single-nucleotide polymorphisms around APOE in Alzheimer disease. Am J Hum Genet 2000; 67: 383–394
   PubMed Web of Science ®Google Scholar
• Epplen C, Santos E J, Maueler W, Van Helden P, Epplen J T. On simple repetitive DNA sequences and complex diseases. Electrophoresis 1997; 18: 1577–1585
   PubMed Web of Science ®Google Scholar
• Usdin K, Grabczyk E. DNA repeat expansions and human disease. Cell Mol Life Sci 2000; 57: 914–931
   PubMed Web of Science ®Google Scholar
• Charra B, Calemard E, Laurent G. Chronic renal failure treatment duration and mode: their relevance to the late dialysis periarticular syndrome. Blood Purif 1988; 6: 117–124
   PubMed Web of Science ®Google Scholar
• Jadoul M, Garbar C, Noel H, Sennesael J, Vanholder R, Bemaert P, Rorive G, Hanique G, Van Ypersele de Strihou C. Histological prevalence of beta 2-microglobulin amyloidosis in hemodialysis: a prospective post-mortem study. Kidney Int 1997; 51: 1928–1932
   PubMed Web of Science ®Google Scholar
• Gejyo F SS, Kimura H, Imura T, Ei I, Hasegawa H, Arakawa M. Increased risk of dialysis-related amyloidosis in patients with the apolipoprotein E4 allele. Amyloid: Int. J. Exp. Clin. Invest 1997; 5: 13–17
   Google Scholar